Cargando…
HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate Cancer
The prognostic value of human leukocyte antigen (HLA) class I molecules in prostate cancer (PCa) remains unclear. Herein, we investigated the prognostic relevance of the most frequently expressed HLA-A alleles in Greece (A*02:01 and HLA-A*24:02) in de novo metastatic hormone-sensitive PCa (mPCa), wh...
Autores principales: | Stokidis, Savvas, Fortis, Sotirios P., Kogionou, Paraskevi, Anagnostou, Theodoros, Perez, Sonia A., Baxevanis, Constantin N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352811/ https://www.ncbi.nlm.nih.gov/pubmed/32570992 http://dx.doi.org/10.3390/cancers12061623 |
Ejemplares similares
-
The Prognostic Significance of Selected HLA Alleles on Prostate Cancer Outcome
por: Stokidis, Savvas, et al.
Publicado: (2023) -
Correction: Kogionou et al. Radiotherapy-Related Gene Signature in Prostate Cancer. Cancers 2022, 14, 5032
por: Kogionou, Paraskevi, et al.
Publicado: (2023) -
Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
por: Goulielmaki, Maria, et al.
Publicado: (2023) -
The impact of radiation therapy on the TCR Vβ chain repertoire in patients with prostate cancer
por: Goulielmaki, Maria, et al.
Publicado: (2022) -
A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer
por: Fortis, Sotirios P., et al.
Publicado: (2023)